SB
Publicaties op Oncologisch.com
First-line pembrolizumab plus chemotherapy for gevorderd HER2-negative gastric or gastroesophageal junction adenocarc...
Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Gevorderd Metastatic Gastroesophageal Adenocarc...
Pembrolizumab plus chemotherapie versus placebo plus chemo bij HER2-negatief maagcarcinoom: KEYNOTE-859 fase III
Olaparib-onderhoud bij BRCA-gemuteerd pancreascarcinoom: POLO definitieve OS